TH

Timothy Haines

Managing Director

Greater London, England

Invests in

Stages:

Locations:

  • Min Investment:

    $15,000,000.00
  • Max Investment:

    $30,000,000.00
  • Target Investment:

    $22,500,000.00

Work Experience

  • Managing Director and Executive Partner

    2023

  • Managing Partner: Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022.

    2022 - 2023

  • Chairman and Managing Partner

    2019 - 2022

  • Managing Partner

    2015 - 2019

  • Partner

    2005 - 2015

2024

  • Chair

    2024

  • Non Executive Chair

    2024

  • Advisory Board Member

    2022

2000 - 2005

  • CEO

    2000 - 2005

    Acquired by Otsuka Pharmaceuticals

1993 - 2000

  • CEO Intervascular Inc. and Patient Monitoring

    1993 - 2000

  • General Manager / VP R and D and Manufacturing

    1990 - 1993

  • CEO

    1987 - 1990

    Acquired by Depuy (J and J) 1990

  • General Manager

    1983 - 1987

Latest Articles